Bulletin
Investor Alert

New York Markets Close in:

Company Close Updates Archives | Email alerts

April 19, 2021, 4:32 p.m. EDT

Johnson & Johnson stock underperforms Monday when compared to competitors despite daily gains

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

or Cancel Already have a watchlist? Log In

MarketWatch Automation

Shares of Johnson & Johnson JNJ inched 0.28% higher to $162.69 Monday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index SPX falling 0.53% to 4,163.26 and Dow Jones Industrial Average DJIA falling 0.36% to 34,077.63. This was the stock's fourth consecutive day of gains. Johnson & Johnson closed $10.96 below its 52-week high ($173.65), which the company achieved on January 26th.

The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Roche Holding AG Part. Cert. RHHVF rose 0.75% to $335.50, Merck & Co. Inc. MRK rose 0.25% to $77.66, and Pfizer Inc. PFE rose 0.93% to $38.93. Trading volume (8.1 M) eclipsed its 50-day average volume of 7.4 M.

Editor's Note: This story was auto-generated by Automated Insights, an automation technology provider, using data from Dow Jones and FactSet. See our market data terms of use.

Get news alerts on Johnson & Johnson — or create your own.
This Story has 0 Comments
Be the first to comment
More News In
Markets

Story Conversation

Commenting FAQs »

Partner Center

Link to MarketWatch's Slice.